Collagen VI alpha-3
COL6A3geneCOL6A3 maintains extracellular matrix integrity in the arterial wall and atherosclerotic plaque, supporting fibrous-cap resistance to degradation.
Pathway placement
Cascade stepFibrous-cap degradation & rupture
Confidencemedium
RationaleConnective-tissue structural gene; aortic matrix integrity links to fibrous-cap stability.
Also acts inLipid entry/oxidation
Druggability
DruggableYes
Known drugs / candidates2
Small-molecule tractableNo
Antibody tractableYes
EnsemblENSG00000163359
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Whole blood — gene is not a circulating analyte; measure protein product or genotype
Collection tube
K2-EDTA whole blood (lavender-top)
Method / principle
SNP genotyping / sequencing; or immunoassay of encoded protein
Reagent / substrate
Allele-specific primers/probes (TaqMan) or NGS panel; or antibody for protein
Platform
qPCR / NGS / array
Turnaround · availability
Send-out · Genotyping widely available; protein assay variable
Human genetic evidence
1
GWAS associations
Traits: myocardial infarction
Literature evidence(2)
- Exploring Potential Drug Targets in Multiple Cardiovascular Diseases: A Study Based on Proteome-Wide Mendelian Randomization and Colocalization Analysis.Cardiovascular therapeutics · 2025 · PMID 40026415 · doi
- Genomic insights in ascending aortic size and distensibility.EBioMedicine · 2021 · PMID 34968759 · doi